NEA Management Company as of Dec. 31, 2019
Portfolio Holdings for NEA Management Company
NEA Management Company holds 47 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ra Pharmaceuticals | 13.6 | $288M | 6.1M | 46.93 | |
| Allakos (ALLK) | 10.2 | $216M | 2.3M | 95.36 | |
| Sprout Social Cl A Ord (SPT) | 6.9 | $145M | 9.0M | 16.05 | |
| Oyster Point Pharma | 6.8 | $145M | 5.9M | 24.44 | |
| Crispr Therapeutics (CRSP) | 6.0 | $127M | 2.1M | 60.90 | |
| Ardelyx (ARDX) | 5.7 | $121M | 16M | 7.50 | |
| Rhythm Pharmaceuticals (RYTM) | 5.3 | $113M | 4.9M | 22.96 | |
| Epizyme | 5.1 | $108M | 4.4M | 24.60 | |
| Aurinia Pharmaceuticals (AUPH) | 5.0 | $105M | 5.2M | 20.26 | |
| Mirum Pharmaceuticals (MIRM) | 4.9 | $103M | 4.2M | 24.52 | |
| Network Associates Inc cl a (NET) | 3.4 | $71M | 4.1M | 17.55 | |
| Mersana Therapeutics (MRSN) | 3.2 | $69M | 12M | 5.73 | |
| Galera Therapeutics (GRTX) | 2.7 | $57M | 4.4M | 13.16 | |
| Dermira | 2.5 | $53M | 3.5M | 15.16 | |
| Glycomimetics (GLYC) | 2.3 | $48M | 9.1M | 5.29 | |
| Phasebio Pharmaceuticals (PHASQ) | 1.9 | $41M | 6.6M | 6.11 | |
| Senseonics Hldgs (SENS) | 1.3 | $28M | 31M | 0.92 | |
| Mei Pharma | 1.0 | $21M | 8.5M | 2.48 | |
| Adaptimmune Therapeutics (ADAP) | 0.9 | $19M | 16M | 1.20 | |
| Obseva Sa | 0.8 | $18M | 4.6M | 3.82 | |
| Affimed Therapeutics B V | 0.8 | $17M | 6.1M | 2.74 | |
| Trevi Therapeutics (TRVI) | 0.8 | $17M | 4.4M | 3.75 | |
| AVEO Pharmaceuticals | 0.7 | $16M | 25M | 0.62 | |
| Genocea Biosciences | 0.7 | $15M | 7.2M | 2.07 | |
| Marker Therapeutics Ord | 0.7 | $14M | 5.0M | 2.88 | |
| Xenon Pharmaceuticals (XENE) | 0.6 | $13M | 992k | 13.11 | |
| Champions Oncology (CSBR) | 0.6 | $13M | 1.6M | 8.33 | |
| Millendo Therapeutics | 0.6 | $12M | 1.8M | 6.74 | |
| Synlogic | 0.5 | $11M | 4.2M | 2.58 | |
| Liquidia Technologies (LQDA) | 0.5 | $11M | 2.5M | 4.28 | |
| Lexicon Pharmaceuticals (LXRX) | 0.5 | $9.9M | 2.4M | 4.15 | |
| Bloom Energy Corp (BE) | 0.5 | $10M | 1.3M | 7.47 | |
| Strongbridge Bioph shs usd | 0.4 | $8.7M | 4.1M | 2.09 | |
| Dasan Zhone Solutions | 0.4 | $8.5M | 956k | 8.86 | |
| Rigel Pharmaceuticals (RIGL) | 0.3 | $6.9M | 3.2M | 2.14 | |
| Verona Pharma Plc ads (VRNA) | 0.3 | $7.0M | 1.2M | 5.75 | |
| Surface Oncology | 0.3 | $6.2M | 3.3M | 1.88 | |
| Cti Biopharma | 0.3 | $5.8M | 3.8M | 1.55 | |
| Erytech Pharma Sa | 0.2 | $4.6M | 625k | 7.37 | |
| X4 Pharmaceuticals (XFOR) | 0.2 | $3.6M | 333k | 10.70 | |
| Trevena | 0.1 | $3.2M | 3.8M | 0.84 | |
| Trillium Therapeutics, Inc. Cmn | 0.1 | $2.2M | 2.1M | 1.03 | |
| Regulus Therapeutics | 0.1 | $1.8M | 2.1M | 0.89 | |
| Tracon Pharmaceuticals | 0.0 | $811k | 347k | 2.34 | |
| Akari Therapeutics | 0.0 | $791k | 452k | 1.75 | |
| Endologix | 0.0 | $394k | 249k | 1.58 | |
| Sunesis Pharmaceuticals Inc Ne | 0.0 | $441k | 1.3M | 0.34 |
